Cargando…
Selected by gene co-expression network and molecular docking analyses, ENMD-2076 is highly effective in glioblastoma-bearing rats
Background: Glioblastoma is the most common type of malignant brain tumor. Bioinformatics technology and structure biology were effectively and systematically used to identify specific targets in malignant tumors and screen potential drugs. Results: GBM patients have higher AURKA and KDR mRNA expres...
Autores principales: | Zhong, Sheng, Bai, Yang, Wu, Bo, Ge, Junliang, Jiang, Shanshan, Li, Weihang, Wang, Xinhui, Ren, Junan, Xu, Haiyang, Chen, Yong, Zhao, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874459/ https://www.ncbi.nlm.nih.gov/pubmed/31706255 http://dx.doi.org/10.18632/aging.102422 |
Ejemplares similares
-
A phase II study of ENMD-2076 in advanced soft tissue sarcoma (STS)
por: Veitch, Zachary, et al.
Publicado: (2019) -
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer
por: Diamond, Jennifer R., et al.
Publicado: (2018) -
Efficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Models of p53-Mutated Triple-Negative Breast Cancer
por: Ionkina, Anastasia A., et al.
Publicado: (2017) -
Computational study on natural compounds inhibitor of c-Myc
por: Ren, Junan, et al.
Publicado: (2020) -
Computational study of novel natural inhibitors targeting aminopeptidase N(CD13)
por: Ge, Junliang, et al.
Publicado: (2020)